EUVIMEDEUVIMED entdecken
Crossref

SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland Results of the 2nd Joint Survey 2024

O Lindner, J Bucerius, T Derlin, W Burchert, R Büchel

Nuklearmedizin - NuclearMedicine · 01.04.2026 · 65 (02) · 143

DOI: 10.1055/s-0046-1818285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.04.2026. Verfasst von O Lindner und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziel/Aim: The 2nd survey on SPECT and PET myocardial perfusion imaging (MPI) imaging in Austria, Germany, and Switzerland aimed to monitor the state of MPI in 2024 and reveal developments from 2021 to 2024. Methodik/Methods: A questionnaire about numbers and procedures of MPI imaging in 2024 was sent to nuclear medicine facilities in Austria, Germany, and Switzerland practicing nuclear medicine. Ergebnisse/Results: Data from 12 Austrian (10,689 SPECT), 198 German (128,707 SPECT), and 15 Swiss departments (11,593 MPI (2,911 SPECT, 8,682 PET)) were analysed. In Austria and Germany, the PET MPI numbers were negligible and not considered. In Austria 50%, in Germany 69%, and in Switzerland 69% of the facilities reported no change or more examinations compared to 2021. Ambulatory care cardiologists represented the major referral group (46-71%). Most stress tests were performed pharmacologically (57-96%). In SPECT imaging the one-day protocol was predominant (77%) in Switzerland, while the two-day protocol was used in Austria (41%) and Germany (49%). The primary camera systems used were SPECT-CT in Austria (75%) and Switzerland (100%), in Germany SPECT cameras (56%). Attenuation correction was regularly performed in Switzerland (100%), followed by Austria (74%) and Germany (35%). Gated SPECT showed high usage (82-99%). Perfusion scoring was frequently performed (Switzerland (88%), Germany (84%), Austria (82%)). Schlussfolgerungen/Conclusion: This 2nd joint survey for 2024 on MPI imaging in Austria, Germany and Switzerland confirms positive trends in MPI imaging in all three countries. Despite differences in procedural issues (stress testing and protocols), the results document a high level of guideline conformity. In terms of Olympic medals, the ranking would be as follows: Switzerland: gold, Austria: silver, and Germany: bronze, with a significant gap to the first ones in terms of technical equipment. Switzerland's gold is based on the wide use of PET MPI, camera equipment, and attenuation correction. Publication History Article published online: 02 April 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Lindner, O., Bucerius, J., Derlin, T., Burchert, W., & Büchel, R. (2026). SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland Results of the 2nd Joint Survey 2024. Nuklearmedizin - NuclearMedicine, 65(02), 143. https://doi.org/10.1055/s-0046-1818285

Vancouver

Lindner O, Bucerius J, Derlin T, Burchert W, Büchel R. SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland Results of the 2nd Joint Survey 2024. Nuklearmedizin - NuclearMedicine. 2026;65(02):143. doi:10.1055/s-0046-1818285

BibTeX
@article{Lindner2026,
  author = {Lindner, O and Bucerius, J and Derlin, T and Burchert, W and Büchel, R},
  title = {SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland Results of the 2nd Joint Survey 2024},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  volume = {65},
  number = {02},
  pages = {143},
  doi = {10.1055/s-0046-1818285}
}
Kostenlos starten →